glp-1 shortage news today 2025 Pipeline Update: November - Prime Therapeutics GLP-1 Receptor Agonist Market Growth
Description
doi: 10.2337/db25-0158
This commentary focuses on emerging pharmacological approaches targeted for the treatment of obesity
10.1016/j.ejphar.2009.12.023 84 McCleanP
- Patches simply peel and stick for continuous health management
GLP-1 research has diversified to include non-alcoholic fatty liver disease, weight loss to help with polycystic ovary syndrome, cardiovascular health, Alzheimers, arthritis and sleep apnea
Angiotensin receptor-neprilysin inhibitors (ARNIs) are another component of medical therapy for HFpEF
